Search

Displaying results 7791 - 7800 of 10000 in total
  1. Drug

    Glesatinib

    go.drugbank.com/drugs/DB06302
    Investigational

  2. Drug

    Onalespib

    go.drugbank.com/drugs/DB06306
    Investigational

  3. Drug

    Avasimibe

    go.drugbank.com/drugs/DB06442
    Experimental

  4. Drug

    Levovirin

    go.drugbank.com/drugs/DB06523
    Experimental

  5. Drug

    TD101

    go.drugbank.com/drugs/DB06596
    Investigational

    TD101, a small interfering RNA (siRNA) designed for the treatment of pachyonychia congenita

  6. Drug

    Anamorelin

    go.drugbank.com/drugs/DB06645
    Investigational

  7. Drug

    Tranilast

    go.drugbank.com/drugs/DB07615
    Investigational

    Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. … Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.

    Synonyms: N-(3,4-Dimethoxycinnamoyl)anthranilic acid
  8. Drug

    MW33

    go.drugbank.com/drugs/DB16358
    Experimental

    [L27411] This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection). … MW33 is a recombinant fully human antibody to SARS-CoV-2.

  9. Drug

    AZD0947

    go.drugbank.com/drugs/DB04848
    Experimental

    As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company’s development pipeline. … AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder.

  10. Drug

    Tanaproget

    go.drugbank.com/drugs/DB04787
    Experimental

    Because of this tanaproget may prove to produce fewer side effects in comparison. It is currently in the process of being developed for clinical use as a contraceptive by Ligand Pharmaceuticals. … An analog of tanaproget, 4-fluoropropyltanaproget (18F), has been developed as a radiotracer for imaging of the PR in positron emission tomography.